Addressing the Rising Prices of Disease-Modifying Therapies for Multiple Sclerosis-Reference-Cited by-同舟云学术

Addressing the Rising Prices of Disease-Modifying Therapies for Multiple Sclerosis

Published:2019-11-01 Issue:11 Volume:76 Page:1285
ISSN:2168-6149
Container-title:JAMA Neurology
language:en
Short-container-title:JAMA Neurol

Author:

Hartung Daniel M.¹,Bourdette Dennis²

Affiliation:

1. College of Pharmacy, Oregon State University/Oregon Health & Science University, Portland

2. Department of Neurology, School of Medicine, Oregon Health & Science University, Portland

Publisher

American Medical Association (AMA)

Subject

Neurology (clinical)

Link

https://jamanetwork.com/journals/jamaneurology/articlepdf/2748919/jamaneurology_hartung_2019_ed_190019.pdf

Reference13 articles.

1. Trends in prices, market share, and spending on self-administered disease-modifying therapies for multiple sclerosis in Medicare Part D;San-Juan-Rodriguez;JAMA Neurol

2. The cost of multiple sclerosis drugs in the US and the pharmaceutical industry: too big to fail?;Hartung;Neurology,2015

3. Economic burden of multiple sclerosis and the role of managed care organizations in multiple sclerosis management.;Owens;Am J Manag Care,2016

4. Trends in coverage for disease-modifying therapies for multiple sclerosis in Medicare Part D.;Hartung;Health Aff (Millwood),2019

5. Economics and cost-effectiveness of multiple sclerosis therapies in the USA.;Hartung;Neurotherapeutics,2017

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Barriers to accessing multiple sclerosis disease-modifying therapies in the Middle East and North Africa region: A regional survey-based study;Multiple Sclerosis and Related Disorders;2023-11

2. Disease activity 4.5 years after starting cladribine: experience in 264 patients with multiple sclerosis;Therapeutic Advances in Neurological Disorders;2023-01

3. Characteristics of Prescription Drug Use Among Individuals With Multiple Sclerosis in the US Medicare Population;International Journal of MS Care;2022-03-01

4. The Neuroimmunology of Multiple Sclerosis: Fictions and Facts;Frontiers in Neurology;2022-02-07

5. Predicting Multiple Sclerosis From Gait Dynamics Using an Instrumented Treadmill: A Machine Learning Approach;IEEE Transactions on Biomedical Engineering;2021-09